D'Este Pablo, Tribó Josep A, García-Romero Antonio
Instituto de Innovación y Gestión del Conocimiento (CSIC-UPV). Ciudad Politécnica de la Innovación. Valencia. España.
Med Clin (Barc). 2008 Dec;131 Suppl 5:66-70. doi: 10.1016/S0025-7753(08)76410-8.
This article examines, on the one hand, the impact of the cooperation between universities and industry on the performance of innovative activities conducted by pharmaceutical firms in Spain and, on the other hand, the article assesses the impact of universities as a source of information for the innovative activities of the Spanish pharmaceutical industry.
Data were drawn from the panel of technological innovation, based on the innovation surveys from 2003 to 2005. The survey included 132 pharmaceutical firms and information was available on the firms' innovative outputs (four indicators), cooperation with universities, and the firms' assessment of the importance of universities as an information source for innovative activities. Firm size, R&D expenditures and the use of biotechnology were used as control variables.
The impact of cooperation with universities was found to be positive and significant (p > 0.01). Moreover, the results show a positive impact of both the use of biotechnology and the use of universities as a source of information on firms' innovative performance (p < 0.01).
Pharmaceutical firms that cooperate with universities are more likely to apply for patents and to be granted them. Moreover, the share of sales from new products is larger among firms that have cooperated with universities than among those that have not.
一方面，本文考察了西班牙大学与企业合作对制药公司创新活动绩效的影响；另一方面，评估了大学作为西班牙制药行业创新活动信息来源的影响。
数据取自技术创新面板，基于2003年至2005年的创新调查。该调查涵盖了132家制药公司，提供了有关公司创新产出（四个指标）、与大学合作以及公司对大学作为创新活动信息来源重要性的评估等信息。公司规模、研发支出和生物技术的使用被用作控制变量。
发现与大学合作的影响是积极且显著的（p>0.01）。此外，结果显示生物技术的使用以及将大学作为信息来源对公司创新绩效均有积极影响（p<0.01）。
与大学合作的制药公司更有可能申请专利并获得批准。此外，与大学合作的公司新产品销售额所占份额高于未合作的公司。
